Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
LowProfitability and efficiency haven't been upto the mark
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Amerise Biosciences Ltd is currently inactive and did not generate any revenue.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Amerise Biosciences Ltd - 531681 - Un-Audited Financial Result Quarter Ending 30Th September, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 | Download
Amerise Biosciences Ltd - 531681 - Un-Audited Financial Result Quarter Ending 30Th September, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 | Download
Amerise Biosciences Ltd - 531681 - Board Meeting Outcome for Un-Audited Financial Result Quarter Ending 30Th September, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 | Download
Amerise Biosciences Ltd - 531681 - Board Meeting Outcome for Un-Audited Financial Result Quarter Ending 30Th September, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015 | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant